与米费普里斯顿相关的子宫内膜变化:一篇评论
1Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
International journal of general medicine
|September 19, 2025
概括
使用米费普里斯顿可能会导致子宫内膜变化,模仿增生症. 低剂量米费普里斯在年轻女性中是安全的,但建议监测雌激素和考虑预防策略.
科学领域:
- 生殖医学 生殖医学
- 内分泌学 在内分泌学.
- 妇科病理学 妇科病理学
背景情况:
- 米菲普里斯是一种孕激素受体调节剂,用于妇科和其他疾病.
- 孕激素受体调节器相关的子宫内膜变化 (PAEC) 正在增加,并模仿子宫内膜增生或癌症.
- 虽然PAECs的分子机制尚未完全理解,但人们怀疑它具有荷尔蒙影响.
研究的目的:
- 调查米费普里斯顿使用的安全性和影响,特别是关于子宫内膜变化.
- 探索PAECs的潜在风险因素和预防策略.
主要方法:
- 对与米费普里斯使用相关的临床数据和组织学发现的审查.
- 对荷尔蒙影响和子宫内膜反应的分析.
- 对低剂量米费普里斯顿治疗方案的安全性概况的评估.
主要成果:
- 在早期卵泡期的年轻女性中,低剂量米费普里斯 (≤10 mg/d) 似乎是安全的.
- 异构性存在于异构性异构性存在于异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构.
- 在治疗前建议对雌激素 (E2) 进行监测.
结论:
- 虽然米菲普里斯的应用越来越广泛,但PAECs是一个新兴的问题.
- 建议进行风险评估和预防策略,如间歇性治疗,超声波和LNG-IUS.
- 谨慎的患者选择和监测对于安全的米费普里斯顿管理至关重要.
关键词:
宫内膜癌 (Endometrial Carcinoma) 是一个体内膜癌.宫内膜变化 宫内膜变化宫内膜的增生是子宫内膜的增生.这就是Mifepristone.孕激素受体调节器相关的子宫内膜变化 (PAECs).更多相关视频
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
1.8K
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
2.0K
相关概念视频
Hormonal Regulation of the Menstrual Cycle
1.5K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.5K
The Menstrual Cycle
3.2K
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
3.2K
Secretory Phase
2.1K
The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
2.1K
Menses Phase
1.0K
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
1.0K
Ovarian Cycle
3.5K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.5K
Disorders of the Female Reproductive System
3.9K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.9K
